Sort   by:  
 Page size 
TranscriptomicsExpression profiling of mouse liver after treatment with Vascular Endothelial Growth Factor (VEGF) inhibitor aflibercept
Transcriptional profiling of mouse liver was compared between VEGF inhibitor aflibercept and control treatment after 9 weeks. 8-10 week-old SCID mice received VEGF Trap protein (aflibercept) subcutaneously twice per week at 25mg per kg body weight for 9 weeks. For control groups, mice were treated...
ORGANISM(S): Mus musculus 
2013-09-01 | E-GEOD-50519 | biostudies-arrayexpress
ProteomicsDifferences in Aqueous Humor Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Aflibercept Treatment
To investigate the changes in aqueous humor (AH) protein profiles before and after intravitreal aflibercept (IVA) treatment in patients with proliferative diabetic retinopathy (PDR) patients. 5 PDR patients provided 10 samples of AH before and after IVA treatment (pre-group vs post-group). Proteins ...
ORGANISM(S): Homo sapiens (Human) 
2024-05-21 | PXD039210 | Pride
Proteomics Aflibercept Proliferative diabetic retinopathy Lc-ms/ms 
TranscriptomicsExpression profiling of mouse liver after treatment with Vascular Endothelial Growth Factor (VEGF) inhibitor aflibercept
Transcriptional profiling of mouse liver was compared between VEGF inhibitor aflibercept and control treatment after 9 weeks.
ORGANISM(S): Mus musculus 
2013-09-01 | GSE50519 | GEO
TranscriptomicsEffects of Aflibercept administration at 25 mg per kg body weight in retinas of mice subjected to the oxygen-induced retinopathy protocol
We aimed at identifying the regulatory network of Aflibercept in the context of pathological neovascularization by using the oxygen-induced retinopathy mouse model as a surrogate of proliferative diabetic retinopathy Total RNA was collected from entire retinal cups dissected from mice subjected to t...
ORGANISM(S): Mus musculus 
2019-10-01 | GSE124956 | GEO
TranscriptomicsEffects of Aflibercept administration at 25 mg per kg body weight in retinas of mice subjected to the oxygen-induced retinopathy protocol [P50]
We aimed at identifying the regulatory network of Aflibercept in the context of pathological neovascularization by using the oxygen-induced retinopathy mouse model as a surrogate of proliferative diabetic retinopathy Total RNA was collected from entire retinal cups dissected from 50-days old mice su...
ORGANISM(S): Mus musculus 
2023-05-18 | GSE150794 | GEO
TranscriptomicsEffects of Aflibercept administration at 25 mg per kg body weight in retinas of mice subjected to the oxygen-induced retinopathy protocol [P19]
We aimed at identifying the regulatory network of Aflibercept in the context of pathological neovascularization by using the oxygen-induced retinopathy mouse model as a surrogate of proliferative diabetic retinopathy Total RNA was collected from entire retinal cups dissected from 19-days old mice su...
ORGANISM(S): Mus musculus 
2021-07-14 | GSE137705 | GEO
UnknownAnalytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference Product.
Not available
S-EPMC11039433 | biostudies-literature
GenomicsEffects of Aflibercept administration at 25 mg per kg body weight in retinas of mice subjected to the oxygen-induced retinopathy protocol [P50]
Effects of Aflibercept administration at 25 mg per kg body weight in retinas of mice subjected to the oxygen-induced retinopathy protocol [P50]
PRJNA633594 | ENA
GenomicsEffects of Aflibercept administration at 25 mg per kg body weight in retinas of mice subjected to the oxygen-induced retinopathy protocol [P19]
Effects of Aflibercept administration at 25 mg per kg body weight in retinas of mice subjected to the oxygen-induced retinopathy protocol [P19]
PRJNA566356 | ENA
UnknownAflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO).
Not available
S-EPMC10630305 | biostudies-literature
Sort   by:  
 Page size